MGRX · Mangoceuticals, Inc.
$0.39
-0.01 (-3.01%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from the date of issuance of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$8.67M
Shares
21.57M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 291,424 | $0.53 | $154,455 |
| 2026-08-13 | 10,452 | $0.53 | $5,540 |
| 2026-08-12 | 124,876 | $0.55 | $68,682 |
| 2026-08-11 | 115,150 | $0.59 | $67,939 |
| 2026-08-10 | 125,304 | $0.49 | $61,399 |
| 2026-08-07 | 387,939 | $0.53 | $205,608 |
| 2026-08-06 | 307,780 | $0.43 | $132,345 |
| 2026-08-05 | 49,407 | $0.46 | $22,727 |
| 2026-08-04 | 504,988 | $0.54 | $272,694 |
| 2026-08-03 | 837,216 | $0.56 | $468,841 |
| 2026-07-31 | 707,733 | $0.29 | $205,243 |
| 2026-07-28 | 21,150 | $0.54 | $11,421 |
| 2026-07-24 | 20,610 | $0.56 | $11,542 |
| 2026-07-22 | 70,263 | $0.47 | $33,024 |
| 2026-07-20 | 28,423 | $0.41 | $11,653 |
| 2026-07-17 | 1,025 | $0.39 | $400 |
| 2026-07-15 | 4,088 | $0.39 | $1,594 |
| 2026-07-14 | 24,863 | $0.36 | $8,951 |
| 2026-07-06 | 100 | $0.47 | $47 |
| 2026-07-02 | 71,296 | $0.43 | $30,657 |
| 2026-07-01 | 14,624 | $0.38 | $5,557 |
| 2026-06-25 | 72,092 | $0.36 | $25,953 |
| 2026-06-24 | 135,895 | $0.35 | $47,563 |
| 2026-06-23 | 442,169 | $0.29 | $128,229 |
| 2026-06-17 | 3,427 | $0.33 | $1,131 |
| 2026-06-16 | 4,856 | $0.36 | $1,748 |
| 2026-06-04 | 34,567 | $0.38 | $13,135 |
| 2026-06-03 | 37,067 | $0.38 | $14,085 |
Showing 1–28 of 28 settlements
Key facts
CIK
1938046
CUSIP
56270V205
13F (30d)
15 filings
15 filers
Visit website
Investor relations